Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LEGN

Legend Biotech (LEGN)

Legend Biotech Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LEGN
DateTimeSourceHeadlineSymbolCompany
12/27/202310:00AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
12/22/20233:38PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
12/22/20233:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
12/21/20235:17PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
12/21/20234:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
12/12/20232:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
12/11/20237:30PMBusiness WirePatient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel)NASDAQ:LEGNLegend Biotech Corporation
11/20/20236:25AMIH Market NewsMonday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and moreNASDAQ:LEGNLegend Biotech Corporation
11/20/20236:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
11/20/20236:00AMBusiness WireLegend Biotech Reports Third Quarter 2023 Results and Recent HighlightsNASDAQ:LEGNLegend Biotech Corporation
11/13/20239:16AMDow Jones NewsLegend Biotech Subsidiary in License Agreement With NovartisNASDAQ:LEGNLegend Biotech Corporation
11/13/20238:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
11/13/20238:30AMBusiness WireLegend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3NASDAQ:LEGNLegend Biotech Corporation
11/07/20238:30AMBusiness WireLegend Biotech to Host Investor Conference Call on Third-Quarter ResultsNASDAQ:LEGNLegend Biotech Corporation
11/02/20239:17AMBusiness WireLegend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual MeetingNASDAQ:LEGNLegend Biotech Corporation
10/17/20235:50PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:LEGNLegend Biotech Corporation
10/17/20235:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
10/17/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
10/16/20235:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
09/27/202312:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
09/25/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
09/22/20234:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
09/22/20234:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
09/18/20234:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LEGNLegend Biotech Corporation
08/28/202310:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
08/21/20234:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
08/15/20236:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
08/15/20236:00AMBusiness WireLegend Biotech Reports Second Quarter 2023 Results and Recent HighlightsNASDAQ:LEGNLegend Biotech Corporation
08/03/20238:30AMBusiness WireLegend Biotech to Host Investor Conference Call on Second-Quarter ResultsNASDAQ:LEGNLegend Biotech Corporation
07/20/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
 Showing the most relevant articles for your search:NASDAQ:LEGN